cefaclor anhydrous has been researched along with Cronobacter Infections in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Esko, E; Renkonen, OV | 1 |
| Mulligan, ME | 1 |
| Bonner, DP; Clark, JM; Dalvi, M; Olsen, SJ; Sykes, RB; Weinberg, DS; Whitney, RR | 1 |
3 other study(ies) available for cefaclor anhydrous and Cronobacter Infections
| Article | Year |
|---|---|
Comparative in vitro activity of norfloxacin and seven other antimicrobial agents against clinical isolates from urinary tract infections.
Topics: Anti-Infective Agents, Urinary; Cefaclor; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Penicillins; Staphylococcal Infections; Staphylococcus; Streptococcal Infections; Streptococcus; Urinary Tract Infections | 1985 |
In vitro activity of cefixime and six other agents against nosocomial pathogens of the Enterobacteriaceae family.
Topics: Ampicillin; Anti-Bacterial Agents; Cefaclor; Cefixime; Cefotaxime; Cephalothin; Cross Infection; Drug Combinations; Enterobacteriaceae; Enterobacteriaceae Infections; Gentamicins; Humans; Microbial Sensitivity Tests; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1987 |
In vivo evaluation of tigemonam, a novel oral monobactam.
Topics: Acute Disease; Administration, Oral; Amoxicillin; Animals; Bacterial Infections; Cefaclor; Cephalexin; Dogs; Enterobacteriaceae Infections; Female; Kinetics; Klebsiella pneumoniae; Male; Mice; Monobactams; Pneumonia; Pyelonephritis; Rats; Rats, Inbred Strains | 1987 |